El misoprostol y el aborto ilegal en Río de Janeiro, Brasil

S H Costa1, M P Vessey

  • 1Department of Epidemiology and Quantitative Methods, National School of Public Health Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.

PubMed
Resumen

El misoprostol es un agente común para el aborto inducido en Brasil, y la mayoría de las mujeres lo usan por vía oral. En comparación con la inserción de catéter, el uso de misoprostol resultó en menos complicaciones como infecciones o lesiones.

Palabras clave:
Enfoque empírico El enfoque empírico.Genética y reproducción.El Río de Janeiro es Río de Janeiro.Los agentes abortivos.Aborto inducido por drogas.Aborto, ilegalmente - las complicaciones.Aborto, inducido por complicaciones.El aborto, el septicemia.Las Américas son las Américas.Biología Biología Biología.El sangrado es sangrado.El Brasil es Brasil.Países en desarrollo Países en desarrollo.Enfermedades Las enfermedades.El sistema endocrino es el sistema endocrino.Planificación familiar La planificación familiar.Control de la fertilidad, después de la concepción.Efectos gastrointestinales en el aparato digestivo.Latinoamérica América Latina América latina América latina América latina América latina América latina América latina América latinaMorbilidad La morbilidad.Fisiología Fisiología Fisiología.Complicaciones del embarazo Complicaciones del embarazoLas glándulas prostaglandularesSeñales y síntomas.América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur América del Sur

Videos de Conceptos Relacionados

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
Birth Control Methods01:22

Birth Control Methods

Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...